Skip to content

Author

F. Rassool

We have 3 of 175 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Cryo-EM structures of autoinhibited and RNA-activated ZNFX1 helicase

Cryo-electron microscopy and biochemical analyses support a regulatory mechanism in which autoinhibited ZNFX1 exists as monomers or concentration-dependent higher-order oligomers, whereas RNA binding promotes structural remodeling and helicase activation.

Qing He, Feng Wang, F. Rassool et al. · 0 citations
Open access Sep 2026

Uncovering pan-cancer signatures of chemoresistance

This is the first comprehensive study that redefines chemoresistance as a proliferative, MYC-driven state and uncover SRM as a tractable vulnerability, offering new avenues for therapeutic intervention across diverse epithelial malignancies.

Mohammed M. A. Inayatullah, Engin Demirdizen, Z. Keepers et al. · 0 citations
Open access Jul 2026

STING agonists in combination with epigenetic drugs potentiate ZNFX1-driven inflammatory necroptosis in TP53 -mutated AML

TP53-mutated AML potentiates effects of novel next-generation STING agonist C92, with unique allosteric and non-cyclic dinucleotide (non-CD) mechanism of action, inducing increased STING activation and cytokine release STING agonists and DNMTis, synergistically increase STING activation with marked transcriptome-wide i...

K. Tripathi, Lora Stojanovic, Zahra Gohari et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.